Overview
Stefan Seregard practices in Stockholm, Sweden. Mr. Seregard is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Uveal Melanoma, Melanoma, Melanoma of the Eye, and Retinoblastoma.
His clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Uveal MelanomaMr. Seregard isDistinguished. Learn about Uveal Melanoma.
- Advanced
- MelanomaMr. Seregard isAdvanced. Learn about Melanoma.
- Melanoma of the EyeMr. Seregard isAdvanced. Learn about Melanoma of the Eye.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Seregard isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Gliomatosis CerebriMr. Seregard isExperienced. Learn about Gliomatosis Cerebri.
- Late-Onset Retinal DegenerationMr. Seregard isExperienced. Learn about Late-Onset Retinal Degeneration.
- Mesenteric Venous ThrombosisMr. Seregard isExperienced. Learn about Mesenteric Venous Thrombosis.
- Metastatic Uveal MelanomaMr. Seregard isExperienced. Learn about Metastatic Uveal Melanoma.
- Retinal DetachmentMr. Seregard isExperienced. Learn about Retinal Detachment.